PCN322 - AN EXAMPLE OF RWE USED FOR HTA EVALUATION- ERLOTINIB RENEGOTIATION IN ITALY
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.404
https://www.valueinhealthjournal.com/article/S1098-3015(18)33704-5/fulltext
Section Title :
Section Order :
2311
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33704-5&doi=10.1016/j.jval.2018.09.404